Randomised phase 3 trial of the addition of mitomycin to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer (ANZUP 1301)

ANZUP

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)147-147
Number of pages1
JournalAsia-Pacific Journal of Clinical Oncology
Volume11
Publication statusPublished - Nov 2015

Cite this